NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Shareholders Approve Proposed Forward Stock Split

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that during its annual general and special meeting of shareholders on May 14, 2018, the proposed forward stock split of PreveCeutical’s issued and outstanding common shares on the basis of five new common shares for each one existing common share was approved by the company’s shareholders. Subject to approval by the Canadian Securities Exchange, the record date for the stock split will be May 24, 2018. On or about May 30, 2018, the company’s transfer agent will issue the additional number of common shares to shareholders of record as a result of the stock split. “We believe the stock split demonstrates the company’s continued commitment to broaden its shareholder base and we anticipate that the stock split will make PreveCeutical’s securities more accessible to investors and enhance liquidity for shareholders,” PreveCeutical CEO, president and chairman Stephen Van Deventer stated in the news release.

To view the full press release, visit http://nnw.fm/94qQ8

About PreveCeutical Medical Inc.

PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs, including: dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury). PreveCeutical sells CELLB9®, an Immune System Booster. CELLB9® is an oral solution containing polarized and potentiated essential minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion venom. This product is available on the company’s website. For more information about PreveCeutical, please visit www.PreveCeutical.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Hammer Fiber Optics Holdings Corp. (HMMR) and 1stPoint Communications Announce Launch of Mobile Network Services Provider Program NetworkNewsBreaks – Emmis Communications Corp. (NASDAQ: EMMS) Posts Fiscal Q4, Full-Year Financial Results NetworkNewsBreaks – EVIO, Inc. (EVIO) Posts Fiscal Q2 2018 Financial Results

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Latest News

Film with Fan Bingbing, Bruce Willis canceled after tax case

Oct 21, 2018

BEIJING — The director of "Air Strike," featuring Chinese actress Fan Bingbing, says the film's release has been canceled in the wake of her disappearance and conviction on tax evasion charges. The World War II thriller, also starring Bruce Willis and Adrien Brody, was to have been released Oct. 26. However, director Xiao Feng posted on his Weibo miniblog Wednesday that it was "time to let go" after eight years of work on the film. Chinese tax authorities this month ordered Fan and companies she represents to pay taxes and penalties totaling $130 million, ending speculation over the fate of...

Federer, del Potro, Zverev all win at Shanghai Masters

Oct 21, 2018

SHANGHAI — Roger Federer had to overcome a second-set stutter. Juan Martin del Potro and Alexander Zverev had to overcome illness. All three still advanced at the Shanghai Masters on Wednesday. Federer, the defending champion, beat Daniil Medvedev 6-4, 4-6, 6-4 in the second round despite being broken late in the second set. "I was able to mix it up. Really also took some chances, serve and volley, second serve," the top-seeded Federer said. "In the third set I really started to figure it out, as well, how aggressive or how tactical I wanted to make the match. And by...

Japanese tycoon going on SpaceX rocket says he trusts Musk

Oct 21, 2018

TOKYO — The Japanese online retail tycoon who plans to travel to the moon on the SpaceX rocket says he respects and trusts Elon Musk as a fellow entrepreneur, despite his recent troubles. "Twitter can get you into trouble," Yusaku Maezawa, chief executive of Zozo Inc., said Tuesday at the Foreign Correspondents' Club in Tokyo. "And that can be said of Elon Musk, too." Musk's tweet in August that declared he had secured financing for a Tesla buyout got him in trouble with the U.S. Securities and Exchange Commission. Under a settlement, Tesla and Musk each must pay a $20...

Hong Kong journalist group protests FT editor's visa denial

Oct 21, 2018

HONG KONG — Hong Kong journalist groups have expressed dismay over the government's refusal to renew a work visa for a Financial Times editor. Representatives from the Hong Kong Foreign Correspondents' Club, Hong Kong Journalists Association and other journalism advocacy groups gathered at the Central Government Offices on Monday and handed a letter of protest to a Hong Kong Government representative. "We are shocked and deeply concerned over the decision by the Hong Kong authorities to refuse a work visa renewal for Victor Mallet, Asia News Editor for the Financial Times," said Chris Yeung of the Hong Kong Journalists Association....

Financial Times says Hong Kong denied editor's visa renewal

Oct 21, 2018

HONG KONG — Hong Kong authorities have refused to renew the work visa of a senior editor of the Financial Times, the newspaper said Friday, a move that came after he chaired a talk by a pro-independence activist that drew Beijing's ire. Rights groups called the rejection the latest sign of Beijing's expanding restrictions on the semi-autonomous Chinese territory. The London-based newspaper said in a statement that it was given no reason why Asia news editor Victor Mallet's application was rejected. "This is the first time we have encountered this situation in Hong Kong," it said. While no direct connection...

Sign up now!